Exelixis Inc (EXEL) earnings · P/E 20, rev $2.32B
These earnings events as JSON? API free 100/dayExelixis Inc (EXEL) is a biotechnology company listed on US.
This EXEL earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported EXEL revenue for 2026-01-02 was $2.32B. Net income was $782.6M. Revenue was up 7.0% from 2025-01-03 to 2026-01-02. EXEL currently screens at market cap $12.69B and trailing P/E 19.6.
When the next EXEL 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 7.0% from 2025-01-03 to 2026-01-02. An earnings headline that ignores that move is noise.
Not investment advice. Full EXEL research stays on the stock page; the tape stays on the quote page.
EXEL earnings FAQ
What are EXEL's latest revenue and net income?
Latest cached Exelixis Inc (EXEL) revenue for Jan 2, 2026 was $2.32B. Net income was $782.6M. Statements: https://lician.com/financials/exel
What is EXEL's latest diluted EPS?
Latest cached Exelixis Inc (EXEL) diluted EPS for Jan 2, 2026 was $2.78.
What period does the latest EXEL earnings print cover?
The latest cached Exelixis Inc (EXEL) earnings print covers Jan 2, 2026. The prior cached period on this page is Jan 3, 2025.
How did EXEL revenue change from the prior cached period?
Cached Exelixis Inc (EXEL) revenue was up 7.0% from $2.17B (Jan 3, 2025) to $2.32B (Jan 2, 2026). Statements: https://lician.com/financials/exel
What is EXEL's P/E ratio?
Exelixis Inc (EXEL) trailing P/E is 19.6 on the latest cached fundamentals snapshot.
Where are EXEL earnings listed?
Cached earnings facts for Exelixis Inc (EXEL) are listed at https://lician.com/earnings/exel. Statements: https://lician.com/financials/exel
Not investment advice.